AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Burcon NutraScience Corporation

$1.08 -$0.18 (-14.29%)
OTC · 15 Sep 2026 19:37 UTC
Previous Close
$1.02
Day Range
$1.08 - $1.08
Year Range
$1.02$1.99
Market Cap
13.71M
AVG Volume
2.36K
Trailing/Forward PE
-1.32/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
01M2M3M4M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
27 Q13.2M
26 Q42.26M
26 Q31.48M
26 Q2804.21K
26 Q1486.97K
25 Q4381.4K
25 Q3338.57K
25 Q2277.07K
25 Q1420.98K
24 Q4184.36K
Net Income (CAD) · TTM
-15M-10M-5M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
27 Q1-14.95M
26 Q4-14.65M
26 Q3-13.3M
26 Q2-11.52M
26 Q1-9.87M
25 Q4-8.26M
25 Q3-8.08M
25 Q2-8.32M
25 Q1-7.4M
24 Q4-7.45M
Operating Income (CAD) · TTM
-15M-10M-5M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
27 Q1-12.14M
26 Q4-11.47M
26 Q3-10.08M
26 Q2-9.21M
26 Q1-8.41M
25 Q4-7.7M
25 Q3-8.03M
25 Q2-8.14M
25 Q1-7.46M
24 Q4-7.47M
EBITDA (CAD) · TTM
-10M-7.5M-5M-2.5M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
27 Q1-9.71M
26 Q4-9.66M
26 Q3-8.55M
26 Q2-8.34M
26 Q1-8.15M
25 Q4-7.43M
25 Q3-7.31M
25 Q2-7.33M
25 Q1-6.56M
24 Q4-6.49M
Cash Flows (CAD) · TTM
-15M-10M-5M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
27 Q1-10.25M
26 Q4-10.65M
26 Q3-8.65M
26 Q2-8.4M
26 Q1-6.62M
25 Q4-5.82M
25 Q3-6.42M
25 Q2-6.47M
25 Q1-6.61M
24 Q4-5.82M
EPS (CAD) · TTM
-1.5-1-0.5024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
27 Q1-1.14
26 Q4-1.11
26 Q3-1.06
26 Q2-1.03
26 Q1-1.08
25 Q4-0.82
25 Q3-0.61
25 Q2-0.37
25 Q1-0.06
24 Q4-0.06
Expenses (CAD) · TTM
02.5M5M7.5M10MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
27 Q14.43M
26 Q44.63M
26 Q35.13M
26 Q25.76M
26 Q16.61M
25 Q47.34M
25 Q38.12M
25 Q28.23M
25 Q17.44M
24 Q47.08M
Shares Outstanding · TTM
-1M-750K-500K-250K024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BRCNF Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
27 Q1-413.17K
26 Q4-538.97K
26 Q3-581.07K
26 Q2-642.14K
26 Q1-674.32K
25 Q4-753.03K
25 Q3-715.23K
25 Q2-807.89K
25 Q1-798.96K
24 Q4-811.15K
PE Ratio
050000100000150000med 63534Jan 21Feb 21Mar 21Apr 21Apr 21May 21Jun 21
BRCNF PE Ratio by quarter
PeriodPE Ratio
Jun 21102162.85
Jun 21100527.82
Jun 2197038.18
Jun 21108035.88
May 21118041.64
May 21126354.73
May 21108898.91
May 21120859.75
Apr 21125038.39
Apr 21134390.11
Apr 21138087.58
Apr 21145322.13
Apr 21128759.91
Mar 2127683.64
Mar 2130029.82
Mar 2126297.56
Mar 2123772.76
Feb 2126184.79
Feb 2129398.67
Feb 2128911.06
Feb 2129290.73
Jan 2121904.41
Jan 2127137.33
Jan 2124009.16
Jan 2124731.7
Dec 2020224.91
Free Cash Flow Yield
-60%-40%-20%0%med -33.99%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BRCNF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-56.02%
Sep 26-54.02%
Sep 26-54.17%
Aug 26-52.95%
Aug 26-50.39%
Aug 26-42.9%
Aug 26-44.94%
Jul 26-45.37%
Jul 26-48.02%
Jul 26-44.01%
Jul 26-44.25%
Jul 26-42.88%
Jun 26-35.06%
Jun 26-30.9%
Jun 26-30.26%
Jun 26-37.04%
May 26-35.31%
May 26-33.79%
May 26-35.67%
May 26-33.23%
May 26-29.51%
Apr 26-29.51%
Apr 26-30.54%
Apr 26-30.59%
Apr 26-34.73%
Mar 26-35.31%
Mar 26-34.47%
Mar 26-29.79%
Mar 26-28.89%
Feb 26-30.73%
Feb 26-33.86%
Feb 26-34.74%
Feb 26-34.11%
Jan 26-34.73%
Jan 26-35.28%
Jan 26-39.01%
Jan 26-39.01%
Jan 26-38.28%
Dec 25-29.37%
Dec 25-29.55%
Dec 25-31.07%
Dec 25-31.75%
Nov 25-28.74%
Nov 25-26.83%
Nov 25-26.98%
Nov 25-21.6%
Oct 25-19.93%
Oct 25-22.47%
Oct 25-23.13%
Oct 25-24.06%
Oct 25-24.15%
Sep 25-24.14%
Sep 25-24.86%
Sep 25-24.45%
Sep 25-25.52%
Aug 25-22.79%
Aug 25-24.92%
Aug 25-22.31%
Aug 25-20.18%
Aug 25-20.62%
Jul 25-21.48%
Jul 25-19.49%
Jul 25-18.93%
Jul 25-17.81%
Jun 25-22.63%
Jun 25-29.54%
Jun 25-35.47%
Jun 25-39.16%
May 25-43.14%
May 25-43.16%
May 25-46.39%
May 25-44.28%
May 25-50.16%
Apr 25-45.16%
Apr 25-45.85%
Apr 25-49.97%
Apr 25-52.32%
Mar 25-45.45%
Mar 25-52.89%
Mar 25-51.11%
Mar 25-49.93%
Feb 25-55.25%
Feb 25-45.44%
Feb 25-46.54%
Feb 25-49.04%
Jan 25-46.11%
Jan 25-48.48%
Jan 25-52.86%
Jan 25-50.14%
Jan 25-50.85%
Dec 24-2.83%
Dec 24-3%
Dec 24-2.87%
Dec 24-2.84%
Nov 24-2.33%
Nov 24-1.79%
Nov 24-1.64%
Nov 24-1.73%
Nov 24-1.67%
Oct 24-1.69%
Price to Sales
02505007501000med 44.08Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BRCNF Price to Sales by quarter
PeriodPrice to Sales
Sep 268.39
Sep 268.71
Sep 268.68
Aug 268.88
Aug 269.33
Aug 2610.96
Aug 2610.47
Jul 2610.37
Jul 269.79
Jul 2610.69
Jul 2610.63
Jul 2610.97
Jun 2616.65
Jun 2618.89
Jun 2619.29
Jun 2615.76
May 2616.54
May 2617.28
May 2616.37
May 2617.57
May 2619.79
Apr 2619.79
Apr 2619.12
Apr 2619.09
Apr 2616.81
Mar 2629.58
Mar 2630.3
Mar 2635.07
Mar 2636.15
Feb 2634
Feb 2630.85
Feb 2630.07
Feb 2630.62
Jan 2630.07
Jan 2629.6
Jan 2626.78
Jan 2626.77
Jan 2627.29
Dec 2546.3
Dec 2546.01
Dec 2543.77
Dec 2542.83
Nov 2547.32
Nov 2550.69
Nov 2550.4
Nov 2562.94
Oct 2568.22
Oct 2560.52
Oct 2558.8
Oct 2556.52
Oct 2556.31
Sep 2563.17
Sep 2561.34
Sep 2562.38
Sep 2559.77
Aug 2566.91
Aug 2561.19
Aug 2568.36
Aug 2575.59
Aug 2573.97
Jul 2570.99
Jul 2578.25
Jul 2580.55
Jul 2585.61
Jun 2583.84
Jun 2564.21
Jun 2553.48
Jun 2548.44
May 2543.98
May 2543.95
May 2540.89
May 2542.84
May 2537.82
Apr 2542
Apr 2541.37
Apr 2537.96
Apr 2536.26
Mar 2551.4
Mar 2544.17
Mar 2545.71
Mar 2546.79
Feb 2542.28
Feb 2551.42
Feb 2550.2
Feb 2547.64
Jan 2550.67
Jan 2548.19
Jan 2544.2
Jan 2546.6
Jan 2545.94
Dec 24554.43
Dec 24523.79
Dec 24547.44
Dec 24554.02
Nov 24675.68
Nov 24877.1
Nov 24955.43
Nov 24910.37
Nov 24941.29
Oct 24928.13
EV/EBITDA
250050007500100001250015000med 7188.04Jan 21Feb 21Apr 21May 21Jul 21Aug 21Sep 21
BRCNF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 217716.14
Sep 218980.71
Sep 2111281.85
Sep 2111767.91
Aug 2111702.02
Aug 2111104.76
Aug 2111903.12
Aug 2112086.3
Jul 2113310.16
Jul 2113014.61
Jul 2111602.18
Jul 2112751.89
Jul 2112487.05
Jun 216074.58
Jun 215977.21
Jun 215769.39
Jun 216424.34
May 217020.21
May 217515.28
May 216475.73
May 217188.04
Apr 217436.89
Apr 217993.81
Apr 218214.01
Apr 218644.85
Apr 217658.52
Mar 216502.07
Mar 217053.78
Mar 216176.13
Mar 215582.42
Feb 216149.61
Feb 216905.36
Feb 216790.7
Feb 216879.98
Jan 215143.07
Jan 216373.6
Jan 215638.01
Jan 215807.91
Dec 204748.13
Price to Book
0100200300med 96.98Apr 24Jul 24Nov 24Feb 25Aug 25Dec 25Mar 26
BRCNF Price to Book by quarter
PeriodPrice to Book
Mar 26184
Mar 26188.46
Mar 26218.1
Mar 26224.86
Feb 26211.44
Feb 26191.86
Feb 26187.02
Feb 26190.47
Jan 26187.05
Jan 26184.13
Jan 26166.56
Jan 26166.52
Jan 26169.72
Dec 256.27
Dec 256.23
Dec 255.93
Dec 255.8
Nov 256.41
Nov 256.86
Nov 256.82
Nov 258.52
Oct 259.23
Oct 258.19
Oct 257.96
Oct 257.65
Oct 257.62
Sep 253.47
Sep 253.37
Sep 253.43
Sep 253.28
Aug 253.68
Aug 253.36
Aug 253.75
Aug 254.15
Aug 254.06
Jul 253.9
Jul 254.3
Jul 254.42
Jul 254.7
Mar 258.6
Mar 257.39
Mar 257.65
Mar 257.83
Feb 257.08
Feb 258.6
Feb 258.4
Feb 257.97
Jan 258.48
Jan 258.06
Jan 257.4
Jan 257.8
Jan 257.69
Dec 2466.9
Dec 2463.2
Dec 2466.06
Dec 2466.85
Nov 2481.53
Nov 24105.84
Nov 24115.29
Nov 24109.85
Nov 24113.58
Oct 24112
Oct 24115.76
Oct 24116.55
Oct 24133.77
Sep 2491.27
Sep 2487.14
Sep 2496.25
Sep 24102.14
Aug 2496.29
Aug 2494.94
Aug 24113.84
Aug 24124.13
Aug 2498.28
Jul 2499.16
Jul 24119.22
Jul 24120.68
Jul 24140.97
Jun 24179.14
Jun 24144.03
Jun 24212.86
Jun 24216.65
May 24221.31
May 24246.35
May 24225.8
May 24226.79
May 24295.51
Apr 24221.38
Apr 24189.66
Apr 24216.41
Apr 24236.13
Mar 24160.41
Mar 24146.65
Mar 24114.87
Mar 2495.19
Mar 24102.73
Feb 2497.67
Feb 24136.69
Feb 24143.63
Feb 2498.08
Burcon NutraScience Corporation
BRCNF
Stockpicker

Video analysis: BRCNF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BRCNF

Burcon Announces Annual General and Special Meeting Date

newsfilecorp.com · 4 Sep 2026

Burcon Announces Annual General and Special Meeting Date

Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce its annual general and special meeting of shareholders (the "AGSM") will be held virtually on September 24, 2026. Burcon has filed the meeting materials on www.sedarplus.ca in connection with its AGSM to be held on September 24, 2026.

Burcon NutraScience Corporation (BU:CA) Q1 2027 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

Burcon NutraScience Corporation (BU:CA) Q1 2027 Earnings Call Transcript

Burcon NutraScience Corporation (BU:CA) Q1 2027 Earnings Call Transcript

Burcon NutraScience Corp (BRCNF) Reports Q1 Loss, Misses Revenue Estimates

zacks.com · 12 Aug 2026

Burcon NutraScience Corp (BRCNF) Reports Q1 Loss, Misses Revenue Estimates

Burcon NutraScience Corp (BRCNF) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.2 per share a year ago.

Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp

newsfilecorp.com · 12 Aug 2026

Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp

Revenue of $1.3 million, up 273% year-over-year and 54% sequentially Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the three months ended June 30, 2026. "Burcon generated a 54% sequential increase in revenue in the quarter ended June 30, 2026, demonstrating accelerating demand for our solutions.

Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026

newsfilecorp.com · 7 Aug 2026

Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026

Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, August 12, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the first quarter of fiscal year 2027.

Are Consumer Staples Stocks Lagging Burcon NutraScience (BRCNF) This Year?

zacks.com · 31 Jul 2026

Are Consumer Staples Stocks Lagging Burcon NutraScience (BRCNF) This Year?

Here is how Burcon NutraScience Corp (BRCNF) and Ryohin Keikaku Co. Ltd. (RYKKY) have performed compared to their sector so far this year.

Is Burcon NutraScience (BRCNF) Stock Outpacing Its Consumer Staples Peers This Year?

zacks.com · 14 Jul 2026

Is Burcon NutraScience (BRCNF) Stock Outpacing Its Consumer Staples Peers This Year?

Here is how Burcon NutraScience Corp (BRCNF) and Ryohin Keikaku Co. Ltd. (RYKKY) have performed compared to their sector so far this year.

Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript

seekingalpha.com · 24 Jun 2026

Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript

Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.